This Serum Wakes Up Zombie-Like Cells in My Skin
It’s an essential in my cold-weather skin care routine.
First FDA-Approved Mesenchymal Stromal Cell Therapy Ushers In A New Era Of Regenerative Medicine
Kimberlin, who previously collaborated with Dr. Jonas Salk to develop the first FDA-approved cell-based immunotherapy, ...
Hosted on MSN1mon
FDA Approves Mesenchymal Stromal Cell Therapy for Refractory Acute GVHD in Kids
Reaching the end of a long road to approval, the first mesenchymal stromal cell (MSC) therapy for steroid-refractory acute graft-versus-host disease (GVHD) finally reached the FDA green light.
Oncology Nurse Advisor6d
Mesenchymal Stromal Cell Therapy Ryoncil Gets FDA Approval
The Food and Drug Administration (FDA) has approved Ryoncil ® (remestemcel-L-rknd) for the treatment of steroid-refractory acute graft vs host disease (SR-aGvHD) in pediatric patients 2 months of age ...
EurekAlert!12d
Stem cell therapy jumpstarts brain recovery after stroke
Scientists at Gladstone Institutes and the regenerative medicine company SanBio have shown that a cell therapy derived from ...
BioWorld7d
BioWorld Asia, Regulatory
As more Asia biotechs turn to regenerative medicine to address disorders without a cure, Medipost Inc. is continuing global expansion with Cartistem, its allogeneic human umbilical cord blood-derived ...
Morningstar12d
First FDA-Approved Mesenchymal Stromal Cell Therapy Ushers in a New Era of Regenerative Medicine
NEW YORK, Jan. 16, 2025 /PRNewswire/ -- The Food and Drug Administration (FDA) approved the first mesenchymal stromal cell (MSC) therapy, RYONCIL®, indicated for steroid-refractory acute graft ...